Ares Life Sciences

Total investments

2

Average round size

27M

Portfolio companies

2

Rounds per year

0.15

Lead investments

2

Exits

1

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareMedical DeviceMedicalPharmaceutical

Summary

In 2008 was created Ares Life Sciences, which is appeared as VC. The main department of described VC is located in the Geneva. The venture was found in Europe in Switzerland.

The top amount of exits for fund were in 2006. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2008.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Ares Life Sciences, startups are often financed by NGN Capital, Menlo Ventures, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are SightLine Partners, Saints Capital, Pac-Link. In the next rounds fund is usually obtained by YA Global Master SPV, Qiming Venture Partners, Intuitive Surgical.

Among the most popular portfolio startups of the fund, we may highlight Broncus Technologies, Santhera Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
2
Exits
1
Rounds per year
0.15
Investments by industry
  • Health Care (2)
  • Medical (1)
  • Medical Device (1)
  • Biotechnology (1)
  • Pharmaceutical (1)
Investments by region
  • United States (1)
  • Switzerland (1)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Group Appearance index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.